These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31318589)

  • 1. Trends and Disparities in Mortality and Progression to AIDS in the Highly Active Antiretroviral Therapy Era: Tennessee, 1996-2016.
    Rebeiro PF; Pettit AC; Sizemore L; Mathieson SA; Wester C; Kipp A; Shepherd BE; Sterling TR
    Am J Public Health; 2019 Sep; 109(9):1266-1272. PubMed ID: 31318589
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
    Huang Y; Zhou O; Zheng Z; Xu Y; Shao Y; Qin C; Qin F; Lai J; Liu H; Chen R; Ye L; Liang H; Qin X; Jiang J
    AIDS Res Ther; 2020 Jul; 17(1):44. PubMed ID: 32680536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort.
    Garriga C; García de Olalla P; Miró JM; Ocaña I; Knobel H; Barberá MJ; Humet V; Domingo P; Gatell JM; Ribera E; Gurguí M; Marco A; Caylà JA;
    PLoS One; 2015; 10(12):e0145701. PubMed ID: 26716982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.
    Melekhin VV; Shepherd BE; Jenkins CA; Stinnette SE; Rebeiro PF; Bebawy SS; Rasbach DA; Hulgan T; Sterling TR
    AIDS Patient Care STDS; 2010 May; 24(5):279-86. PubMed ID: 20438375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort study.
    Coelho L; Grinsztejn B; Castilho JL; De Boni R; Quintana MS; Campos DP; Ribeiro SR; Pacheco AG; Veloso VG; Luz PM
    Lancet HIV; 2016 Oct; 3(10):e490-8. PubMed ID: 27658875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study.
    Gheibi Z; Shayan Z; Joulaei H; Fararouei M; Beheshti S; Shokoohi M
    BMC Infect Dis; 2019 Dec; 19(1):1094. PubMed ID: 31888541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial-ethnic differences in all-cause and HIV mortality, Florida, 2000-2011.
    Trepka MJ; Fennie KP; Sheehan DM; Niyonsenga T; Lieb S; Maddox LM
    Ann Epidemiol; 2016 Mar; 26(3):176-82.e1. PubMed ID: 26948103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of progression to AIDS and death following HIV diagnosis: a retrospective cohort study in Wuhan, China.
    Jiang H; Xie N; Cao B; Tan L; Fan Y; Zhang F; Yao Z; Liu L; Nie S
    PLoS One; 2013; 8(12):e83078. PubMed ID: 24376638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013.
    Zhang G; Gong Y; Wang Q; Deng L; Zhang S; Liao Q; Yu G; Wang K; Wang J; Ye S; Liu Z
    Medicine (Baltimore); 2016 Jul; 95(27):e3969. PubMed ID: 27399071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.
    Murphy K; Hoover DR; Shi Q; Cohen M; Gandhi M; Golub ET; Gustafson DR; Pearce CL; Young M; Anastos K
    AIDS; 2013 Sep; 27(15):2413-23. PubMed ID: 24037210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin].
    Guo Y; Zhou N; Zhao FN; Liu ZQ; Li L; Yu MH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Aug; 40(8):936-940. PubMed ID: 31484257
    [No Abstract]   [Full Text] [Related]  

  • 13. The 2013 HIV Continuum of Care in Tennessee: Progress Made, but Disparities Persist.
    Wester C; Rebeiro PF; Shavor TJ; Shepherd BE; McGoy SL; Daley B; Morrison M; Vermund SH; Pettit AC
    Public Health Rep; 2016 Sep; 131(5):695-703. PubMed ID: 28123210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.
    Anastos K; Barrón Y; Miotti P; Weiser B; Young M; Hessol N; Greenblatt RM; Cohen M; Augenbraun M; Levine A; Muñoz A;
    Arch Intern Med; 2002 Sep; 162(17):1973-80. PubMed ID: 12230420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women.
    Jarrin I; Geskus R; Bhaskaran K; Prins M; Perez-Hoyos S; Muga R; Hernández-Aguado I; Meyer L; Porter K; del Amo J;
    Am J Epidemiol; 2008 Sep; 168(5):532-40. PubMed ID: 18663213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era.
    Grinsztejn B; Luz PM; Pacheco AG; Santos DV; Velasque L; Moreira RI; Guimarães MR; Nunes EP; Lemos AS; Ribeiro SR; Campos DP; Vitoria MA; Veloso VG
    PLoS One; 2013; 8(4):e59768. PubMed ID: 23577074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiretroviral therapy initiation time and baseline CD4
    Yang Y; Li Y; Zhang X; Zhang W; Ma Y; Jia X; Gondwe T; Wang Y; Shi X
    Glob Health Action; 2021 Jan; 14(1):1963527. PubMed ID: 34592916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and Differences Among Three New Indicators of HIV Infection Progression.
    An Q; Song R; Hernandez A; Hall HI
    Public Health Rep; 2015; 130(5):468-74. PubMed ID: 26327725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China.
    Zhu Z; Xu Y; Wu S; Li X; Shi H; Dong X; Xu W
    Front Public Health; 2022; 10():989127. PubMed ID: 36339239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
    Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
    AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.